Viewing Study NCT02602067


Ignite Creation Date: 2025-12-25 @ 12:37 AM
Ignite Modification Date: 2026-02-28 @ 12:03 AM
Study NCT ID: NCT02602067
Status: TERMINATED
Last Update Posted: 2018-09-18
First Post: 2015-11-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: 131Iodine-Tenatumomab Treatment in Tenascin-C Positive Cancer Patients
Sponsor: sigma-tau i.f.r. S.p.A.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module